For years, healthcare providers have treated children as miniature adults by prescribing them drugs approved for adult use (albeit at lower doses). But the FDA and other federal agencies are pushing for proof that these drugs are appropriate for younger patients and urging more pediatric-only trials or trials that enroll both adult and pediatric participants.